GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,000 | -4.5% | 491 | 0.0% | 0.01% | +9.1% |
| Q4 2021 | $22,000 | +15.8% | 491 | 0.0% | 0.01% | +10.0% |
| Q3 2021 | $19,000 | -5.0% | 491 | 0.0% | 0.01% | -9.1% |
| Q2 2021 | $20,000 | -70.6% | 491 | -73.9% | 0.01% | -71.1% |
| Q1 2021 | $68,000 | +54.5% | 1,882 | +58.0% | 0.04% | +22.6% |
| Q4 2020 | $44,000 | -42.9% | 1,191 | -41.9% | 0.03% | -55.7% |
| Q3 2020 | $77,000 | -18.1% | 2,051 | -11.5% | 0.07% | -27.1% |
| Q2 2020 | $94,000 | +2.2% | 2,318 | -4.6% | 0.10% | -17.9% |
| Q1 2020 | $92,000 | -29.2% | 2,430 | -19.9% | 0.12% | +37.6% |
| Q3 2019 | $130,000 | +4.8% | 3,035 | -2.4% | 0.08% | +2.4% |
| Q2 2019 | $124,000 | -26.2% | 3,110 | -22.7% | 0.08% | -35.7% |
| Q1 2019 | $168,000 | -22.9% | 4,021 | -25.9% | 0.13% | +22.9% |
| Q3 2018 | $218,000 | – | 5,430 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |